Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1333493/000133349323000063/ehth-20230331.htm
August 2023
June 2023
May 2023
May 2023
February 2023
February 2023
January 2023
December 2022
November 2022
November 2022
CEO Comments | ||||||||
“We delivered strong first quarter performance, reflecting the positive impact of the transformation plan that we started to implement in Q2 of 2022. We entered the first quarter of this year on a significantly improved cost foundation compared to the first quarter of last year while continuing to enhance our telesales conversions, member economics and enrollment quality. eHealth observed another 50% year-over-year decrease in its CTM rates from Q1 2022 to Q1 2023 based on data available to-date. Many of our key carrier partners have recognized this important service improvement. Based on our encouraging first quarter results, we are reaffirming the guidance ranges we gave on last quarter’s earnings call for 2023. Our year-to-date performance has put us in a strong position as we continue to execute on our strategic and operational goals. We look forward to sharing more information about our business, strategy, and longer-term financial goals at our investor day, on May 18th.” – Fran Soistman, Chief Executive Officer |
Results Overview |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1333493/000133349323000063/ehth-20230331.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Ehealth, Inc..
Ehealth, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:
Rating
Learn More![]()
Some of our marketing partners have tiered arrangements where the amount we pay the marketing partner per submitted application increases as the volume of submitted applications we receive from the marketing partner increases.
The constraints are applied to help ensure that commissions estimated to be collected over the estimated life of an approved member's plan are recognized as revenue only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with future commissions receivable from the plan is subsequently resolved.
Our effective tax rate for the three months ended March 31, 2023 was lower than the statutory federal tax rate due primarily to stock-based compensation adjustments and non-deductible lobbying expenses, partially offset by research and development credits and state taxes.
If we fail to declare and pay full cash dividend payments as required by the certificate of designations for the Series A preferred stock for two consecutive Cash Dividend Payment Dates, the cash dividend rate then in effect shall increase one time by 2%, retroactive to the first day of the semiannual period immediately preceding the first Cash Dividend Payment Date at which we failed to pay such accrued cash dividends, until such failure to pay full cash dividends is cured (at which time the dividend rate shall return to the rate prior to such increase).
Our plan recommendation tool curates this broad plan selection by analyzing customer health-related information against plan data for insurance coverage fit.
This was primarily due to...Read more
The decrease in variable advertising...Read more
Recent Accounting Pronouncements See Note...Read more
The Amendment replaced the LIBOR-based...Read more
To a lesser extent, the...Read more
Variable marketing costs exclude fixed...Read more
Dividends on our outstanding shares...Read more
The Medicare segment consists primarily...Read more
The constrained LTV of commissions...Read more
This plan has incorporated different...Read more
Increases in submitted applications resulting...Read more
Since our marketing and advertising...Read more
Member Acquisition Marketing initiatives are...Read more
Adjustments for non-cash items primarily...Read more
Adjustments for non-cash items primarily...Read more
Three Months Ended March 31,...Read more
For ancillary health insurance plans,...Read more
CC&E cost per IFP-equivalent approved...Read more
The base rate was the...Read more
Constrained LTV of commissions per...Read more
The following table shows estimated...Read more
The decrease in Medicare segment...Read more
A portion of our technology...Read more
The base rate is the...Read more
Three Months Ended March 31,...Read more
Variable marketing costs represent direct...Read more
27 Estimated Constrained Lifetime Value...Read more
In the first quarter of...Read more
The increase was primarily due...Read more
We plan to continue improving...Read more
In periods of membership growth,...Read more
The increase was primarily driven...Read more
Other revenue decreased $5.7 million,...Read more
Variable marketing cost per IFP-equivalent...Read more
We continue to leverage our...Read more
Our operating segment revenue and...Read more
Our marketing and advertising expenses...Read more
We have created a consumer-centric...Read more
The outstanding obligations under the...Read more
Our Individual, Family and Small...Read more
Overview We are a leading...Read more
During the Medicare annual enrollment...Read more
The increase in commission revenue...Read more
35 Our other expense, net...Read more
We terminated our credit agreement...Read more
We believe our current cash...Read more
We have implemented a multi-year...Read more
Cash provided by changes in...Read more
The timing of open enrollment...Read more
Over the last several months,...Read more
The decrease in operating expenses...Read more
Our future capital requirements will...Read more
Segment Profit (Loss) Three Months...Read more
Customer Care and Enrollment Customer...Read more
The numerator used to calculate...Read more
Our platform leverages technology to...Read more
Three Months Ended March 31,...Read more
Cash provided by changes in...Read more
Variable marketing cost per MA-equivalent...Read more
If we experience a significant...Read more
34 Our technology and content...Read more
Financing Activities Three Months Ended...Read more
Our omnichannel consumer engagement platform...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Ehealth, Inc. provided additional information to their SEC Filing as exhibits
Ticker: EHTH
CIK: 1333493
Form Type: 10-Q Quarterly Report
Accession Number: 0001333493-23-000063
Submitted to the SEC: Tue May 09 2023 4:36:11 PM EST
Accepted by the SEC: Tue May 09 2023
Period: Friday, March 31, 2023
Industry: Insurance Agents Brokers And Service